Annual EBIT
-$25.07 M
-$10.19 M-68.49%
December 31, 2023
Summary
- As of March 10, 2025, CNTX annual earnings before interest & taxes is -$25.07 million, with the most recent change of -$10.19 million (-68.49%) on December 31, 2023.
- During the last 3 years, CNTX annual EBIT has fallen by -$32.38 million (-443.19%).
- CNTX annual EBIT is now -443.19% below its all-time high of $7.31 million, reached on December 31, 2020.
Performance
CNTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$18.70 M
-$15.61 M-505.52%
September 30, 2024
Summary
- As of March 10, 2025, CNTX quarterly earnings before interest & taxes is -$18.70 million, with the most recent change of -$15.61 million (-505.52%) on September 30, 2024.
- Over the past year, CNTX quarterly EBIT has stayed the same.
- CNTX quarterly EBIT is now -344.96% below its all-time high of $7.63 million, reached on June 30, 2020.
Performance
CNTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$32.55 M
-$12.52 M-62.52%
September 30, 2024
Summary
- As of March 10, 2025, CNTX TTM earnings before interest & taxes is -$32.55 million, with the most recent change of -$12.52 million (-62.52%) on September 30, 2024.
- Over the past year, CNTX TTM EBIT has stayed the same.
- CNTX TTM EBIT is now -470.81% below its all-time high of $8.78 million, reached on June 30, 2020.
Performance
CNTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CNTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.5% | 0.0% | 0.0% |
| 3 y3 years | -443.2% | 0.0% | 0.0% |
| 5 y5 years | -374.5% | 0.0% | 0.0% |
CNTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -141.3% | at low | -505.5% | at low | -213.2% | at low |
| 5 y | 5-year | -443.2% | at low | -345.0% | at low | -470.8% | at low |
| alltime | all time | -443.2% | at low | -345.0% | at low | -470.8% | at low |
Context Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.70 M(+505.5%) | -$32.55 M(+62.5%) |
| Jun 2024 | - | -$3.09 M(-19.2%) | -$20.03 M(-9.9%) |
| Mar 2024 | - | -$3.82 M(-44.9%) | -$22.23 M(-11.3%) |
| Dec 2023 | -$25.07 M(+68.5%) | -$6.93 M(+12.2%) | -$25.07 M(+13.9%) |
| Sep 2023 | - | -$6.18 M(+16.8%) | -$22.02 M(+10.7%) |
| Jun 2023 | - | -$5.29 M(-20.6%) | -$19.89 M(+9.9%) |
| Mar 2023 | - | -$6.67 M(+71.7%) | -$18.10 M(+21.7%) |
| Dec 2022 | -$14.88 M | -$3.88 M(-4.1%) | -$14.88 M(-12.7%) |
| Sep 2022 | - | -$4.05 M(+15.4%) | -$17.05 M(+17.0%) |
| Jun 2022 | - | -$3.51 M(+1.9%) | -$14.57 M(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.44 M(-43.1%) | -$13.00 M(+25.0%) |
| Dec 2021 | -$10.39 M(-242.3%) | -$6.05 M(+285.6%) | -$10.39 M(+106.3%) |
| Sep 2021 | - | -$1.57 M(-19.1%) | -$5.04 M(+18.5%) |
| Jun 2021 | - | -$1.94 M(+130.6%) | -$4.25 M(-179.8%) |
| Mar 2021 | - | -$840.30 K(+21.7%) | $5.32 M(-27.1%) |
| Dec 2020 | $7.31 M(-238.3%) | -$690.30 K(-11.6%) | $7.31 M(-8.6%) |
| Sep 2020 | - | -$781.00 K(-110.2%) | $8.00 M(-8.9%) |
| Jun 2020 | - | $7.63 M(+568.2%) | $8.78 M(+668.2%) |
| Mar 2020 | - | $1.14 M | $1.14 M |
| Dec 2019 | -$5.28 M | - | - |
FAQ
- What is Context Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Context Therapeutics?
- What is Context Therapeutics annual EBIT year-on-year change?
- What is Context Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Context Therapeutics?
- What is Context Therapeutics quarterly EBIT year-on-year change?
- What is Context Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Context Therapeutics?
- What is Context Therapeutics TTM EBIT year-on-year change?
What is Context Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CNTX is -$25.07 M
What is the all time high annual EBIT for Context Therapeutics?
Context Therapeutics all-time high annual earnings before interest & taxes is $7.31 M
What is Context Therapeutics annual EBIT year-on-year change?
Over the past year, CNTX annual earnings before interest & taxes has changed by -$10.19 M (-68.49%)
What is Context Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CNTX is -$18.70 M
What is the all time high quarterly EBIT for Context Therapeutics?
Context Therapeutics all-time high quarterly earnings before interest & taxes is $7.63 M
What is Context Therapeutics quarterly EBIT year-on-year change?
Over the past year, CNTX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Context Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CNTX is -$32.55 M
What is the all time high TTM EBIT for Context Therapeutics?
Context Therapeutics all-time high TTM earnings before interest & taxes is $8.78 M
What is Context Therapeutics TTM EBIT year-on-year change?
Over the past year, CNTX TTM earnings before interest & taxes has changed by $0.00 (0.00%)